Retin-A Shortage Update: What Patients Need to Know in 2026

If you've been struggling to fill your Retin-A or tretinoin prescription in 2026, you're not alone. Patients across the country have been reporting inconsistent availability at their local pharmacies. Here's a clear, up-to-date breakdown of the situation and what you can do about it.

Current FDA Status: Is Retin-A in a Formal Shortage?

As of 2026, the FDA's official Drug Shortage Database does not list topical tretinoin (cream or gel) as being in a formal shortage. The shortage listing that does exist for tretinoin is specific to oral tretinoin capsules — a completely different product used to treat acute promyelocytic leukemia (APL), a type of blood cancer.

However, the absence of a formal FDA shortage designation doesn't mean that topical tretinoin is universally easy to find. Many patients experience real pharmacy-level stocking gaps that make it frustrating to fill their prescription.

What's Driving the Availability Issues in 2026?

Several factors are creating real-world availability challenges for Retin-A and generic tretinoin even without an official shortage:

• Massive demand increase: Tretinoin has seen explosive demand growth fueled by social media, telehealth platforms, and growing awareness of its effectiveness for both acne and anti-aging. The global tretinoin market was valued at $1.8 billion in 2025 and is projected to reach $3.2 billion by 2034.
• Pharmacy stocking practices: Chain pharmacies use automated ordering systems based on past dispensing data. When demand spikes at a location, the reorder may take several days to arrive. Individual pharmacy shelves can be bare even when the national supply is adequate.
• Multiple formulations fragmenting supply: Retin-A is available in cream, gel, and gel microsphere forms, with concentrations from 0.01% to 0.1%. Each variation is stocked separately, meaning a pharmacy may have 0.025% cream but not 0.05% cream.
• Telehealth prescription volume: Online dermatology platforms have dramatically increased the volume of tretinoin prescriptions being sent to retail pharmacies. Some local pharmacies haven't been able to keep up with this demand surge.

Is the Situation Getting Better or Worse?

The underlying supply fundamentals have actually improved over the past two years. New generic manufacturers have entered the market — for example, Alembic Pharmaceuticals launched a generic tretinoin 0.1% cream in June 2024 — increasing competition and supply diversity.

However, demand continues to grow faster than pharmacy stocking practices can adapt. The result is a paradox: national supply is adequate, but local pharmacy availability remains unpredictable. This is more of an availability distribution problem than a manufacturing shortage.

Which Patients Are Most Affected?

Availability issues most often affect patients seeking:

• Less common strengths (e.g., 0.01% gel, 0.1% cream) at small or rural pharmacies
• Brand-name Retin-A Micro (tretinoin gel microsphere) rather than generic versions
• Patients in areas with few nearby pharmacies who can't easily shop around
• Patients whose telehealth prescription was sent to a single pharmacy without checking stock first

What Should Patients Do Right Now?

Here are the most effective steps to take if your pharmacy is out of Retin-A:

1. Use medfinder to find which pharmacies near you have your specific strength in stock — rather than calling each one yourself.
2. Ask your pharmacist to place a special order from their wholesaler. Many pharmacies can get stock within 1-2 business days.
3. Contact your dermatologist or prescriber — they may be able to adjust your strength, switch to gel vs. cream, or refer you to a compounding pharmacy.
4. Consider mail-order — online pharmacies often have more consistent tretinoin stock than local brick-and-mortar stores.
5. If you'll be without treatment for more than 1-2 weeks, ask about adapalene (Differin) as a temporary bridge — it's available OTC and works by a similar mechanism.

The Bottom Line

There is no FDA-declared shortage of topical Retin-A in 2026, but real-world availability gaps are common due to surging demand and reactive pharmacy stocking. The medication is available — the challenge is finding it. Use medfinder to locate pharmacies near you with stock, and speak with your prescriber if you need flexibility on formulation or strength. For information on what to use while you wait, see our guide on Alternatives to Retin-A If You Can't Fill Your Prescription.